scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1041920572 |
P356 | DOI | 10.1038/SJ.LEU.2404709 |
P698 | PubMed publication ID | 17476281 |
P50 | author | Marcos González Díaz | Q5996580 |
Josep Nomdedeu | Q50238034 | ||
Mar Tormo | Q53101846 | ||
Maria José Terol | Q55445053 | ||
M J Calasanz | Q67566883 | ||
Ana Lluch | Q67755317 | ||
Vicente Martin Guillem | Q73275907 | ||
P2093 | author name string | Bolufer P | |
Collado M | |||
Esteve J | |||
Sanzo C | |||
P2860 | cites work | A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase | Q24324172 |
XRCC1 is required for DNA single-strand break repair in human cells | Q24796404 | ||
A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells | Q28369118 | ||
Score tests for association between traits and haplotypes when linkage phase is ambiguous | Q29616281 | ||
The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance | Q29616511 | ||
Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia | Q32073276 | ||
Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. | Q33944747 | ||
A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. | Q34025724 | ||
The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia | Q34155718 | ||
Genetic predisposition and treatment-related leukemia | Q34243517 | ||
The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function | Q34290755 | ||
A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? | Q34385362 | ||
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. | Q35080478 | ||
5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview | Q35097747 | ||
Structural perturbations in the Ala --> Val polymorphism of methylenetetrahydrofolate reductase: how binding of folates may protect against inactivation | Q35792429 | ||
Therapy-related leukemia and myelodysplasia: evolving concepts of pathogenesis and treatment | Q35809447 | ||
Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia | Q36600942 | ||
Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck | Q38318875 | ||
Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate | Q40597353 | ||
Regulatory studies of murine methylenetetrahydrofolate reductase reveal two major promoters and NF-kappaB sensitivity | Q42808297 | ||
The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine | Q43631868 | ||
A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk | Q43787664 | ||
Polymorphisms in methylenetetrahydrofolate reductase and methotrexate sensitivity in childhood acute lymphoblastic leukemia | Q43963806 | ||
Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate | Q44230880 | ||
Genotype and haplotype distributions of MTHFR677C>T and 1298A>C single nucleotide polymorphisms: a meta-analysis. | Q44298677 | ||
Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients. | Q45193940 | ||
Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity | Q45285628 | ||
Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia | Q46410865 | ||
MTHFR genotypes and breast cancer survival after surgery and chemotherapy: a report from the Shanghai Breast Cancer Study | Q46469731 | ||
MLL gene rearrangements have no direct impact on Ara-C sensitivity in infant acute lymphoblastic leukemia and childhood M4/M5 acute myeloid leukemia | Q46819261 | ||
MTHFR 677 (C-->T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95. | Q46931731 | ||
XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. | Q53396019 | ||
SNPStats: a web tool for the analysis of association studies. | Q53731244 | ||
Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia | Q73215627 | ||
Therapy related acute myeloid leukemia after exposure to 5-fluorouracil: a case report | Q73393250 | ||
Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies | Q73446152 | ||
P433 | issue | 7 | |
P304 | page(s) | 1413-1422 | |
P577 | publication date | 2007-05-03 | |
P1433 | published in | Leukemia | Q6534498 |
P1476 | title | Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies | |
P478 | volume | 21 |
Q34450001 | A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk |
Q37855227 | An integrated genomic approach to the assessment and treatment of acute myeloid leukemia. |
Q35106332 | Association between MTHFR polymorphisms and acute myeloid leukemia risk: a meta-analysis |
Q38861651 | Associations of NQO1 C609T and NQO1 C465T polymorphisms with acute leukemia risk: a PRISMA-compliant meta-analysis. |
Q38403345 | Comprehensive assessment of the association between DNA repair gene XRCC3 Thr241Met polymorphism and leukemia risk |
Q33606720 | Gene-gene interactions in the folate metabolic pathway and the risk of conotruncal heart defects |
Q35117677 | Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors |
Q38063197 | Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia |
Q60907615 | Polymorphisms in MDM2 and TP53 Genes and Risk of Developing Therapy-Related Myeloid Neoplasms |
Q34411659 | Polymorphisms in XPC provide prognostic information in acute myeloid leukemia |
Q36605135 | Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia |
Q57127326 | Problems to affect long-term survival for breast cancer patients: An observational study of subsequent lung/bronchus malignancies |
Q52653738 | Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study. |
Q37009760 | Therapy-related myeloid leukemia. |
Q38039381 | What's all the fuss about? facts and figures about bone marrow failure and conditions |
Search more.